世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5010
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・気道感染症治療の市場動向
・企業の競争状況、市場シェア
・気道感染症治療の種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）
・気道感染症治療の用途別市場規模（病院、診療所）
・気道感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・気道感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・気道感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・気道感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・気道感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott、AstraZeneca、Abbvie、Boehringer Ingelheim、Cipla Pharmaceutical、GlaxoSmithkline、Pfizer、Merck、Novartis、Roche、Sanofi、Teva）
・結論

Market Analysis and Insights: Global Respiratory Tract Infection Treatment Market
The global Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Tract Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Tract Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Tract Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Tract Infection Treatment market.

Global Respiratory Tract Infection Treatment Scope and Market Size
Respiratory Tract Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Tract Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
NSAIDS
Cough Suppressant
Nose Decongestant
Others

Segment by Application
Hospital
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
AstraZeneca
Abbvie
Boehringer Ingelheim
Cipla Pharmaceutical
GlaxoSmithkline
Pfizer
Merck
Novartis
Boehringer Ingelheim

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Tract Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 NSAIDS
1.2.4 Cough Suppressant
1.2.5 Nose Decongestant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Respiratory Tract Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Tract Infection Treatment Market Perspective (2016-2027)
2.2 Respiratory Tract Infection Treatment Growth Trends by Regions
2.2.1 Respiratory Tract Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Tract Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Tract Infection Treatment Industry Dynamic
2.3.1 Respiratory Tract Infection Treatment Market Trends
2.3.2 Respiratory Tract Infection Treatment Market Drivers
2.3.3 Respiratory Tract Infection Treatment Market Challenges
2.3.4 Respiratory Tract Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Tract Infection Treatment Players by Revenue
3.1.1 Global Top Respiratory Tract Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Respiratory Tract Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Tract Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Tract Infection Treatment Revenue
3.4 Global Respiratory Tract Infection Treatment Market Concentration Ratio
3.4.1 Global Respiratory Tract Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Tract Infection Treatment Revenue in 2020
3.5 Respiratory Tract Infection Treatment Key Players Head office and Area Served
3.6 Key Players Respiratory Tract Infection Treatment Product Solution and Service
3.7 Date of Enter into Respiratory Tract Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Tract Infection Treatment Breakdown Data by Type
4.1 Global Respiratory Tract Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Tract Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Respiratory Tract Infection Treatment Breakdown Data by Application
5.1 Global Respiratory Tract Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Tract Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Respiratory Tract Infection Treatment Market Size (2016-2027)
6.2 North America Respiratory Tract Infection Treatment Market Size by Type
6.2.1 North America Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
6.3 North America Respiratory Tract Infection Treatment Market Size by Application
6.3.1 North America Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
6.4 North America Respiratory Tract Infection Treatment Market Size by Country
6.4.1 North America Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Respiratory Tract Infection Treatment Market Size (2016-2027)
7.2 Europe Respiratory Tract Infection Treatment Market Size by Type
7.2.1 Europe Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Respiratory Tract Infection Treatment Market Size by Application
7.3.1 Europe Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Respiratory Tract Infection Treatment Market Size by Country
7.4.1 Europe Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Respiratory Tract Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Tract Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Respiratory Tract Infection Treatment Market Size (2016-2027)
9.2 Latin America Respiratory Tract Infection Treatment Market Size by Type
9.2.1 Latin America Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Respiratory Tract Infection Treatment Market Size by Application
9.3.1 Latin America Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Respiratory Tract Infection Treatment Market Size by Country
9.4.1 Latin America Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Respiratory Tract Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Tract Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Respiratory Tract Infection Treatment Introduction
11.1.4 Abbott Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Respiratory Tract Infection Treatment Introduction
11.2.4 AstraZeneca Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Abbvie
11.3.1 Abbvie Company Details
11.3.2 Abbvie Business Overview
11.3.3 Abbvie Respiratory Tract Infection Treatment Introduction
11.3.4 Abbvie Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.3.5 Abbvie Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Respiratory Tract Infection Treatment Introduction
11.4.4 Boehringer Ingelheim Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Cipla Pharmaceutical
11.5.1 Cipla Pharmaceutical Company Details
11.5.2 Cipla Pharmaceutical Business Overview
11.5.3 Cipla Pharmaceutical Respiratory Tract Infection Treatment Introduction
11.5.4 Cipla Pharmaceutical Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.5.5 Cipla Pharmaceutical Recent Development
11.6 GlaxoSmithkline
11.6.1 GlaxoSmithkline Company Details
11.6.2 GlaxoSmithkline Business Overview
11.6.3 GlaxoSmithkline Respiratory Tract Infection Treatment Introduction
11.6.4 GlaxoSmithkline Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.6.5 GlaxoSmithkline Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Respiratory Tract Infection Treatment Introduction
11.7.4 Pfizer Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Respiratory Tract Infection Treatment Introduction
11.8.4 Merck Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Respiratory Tract Infection Treatment Introduction
11.9.4 Novartis Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Respiratory Tract Infection Treatment Introduction
11.10.4 Roche Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Respiratory Tract Infection Treatment Introduction
11.11.4 Sanofi Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Respiratory Tract Infection Treatment Introduction
11.12.4 Teva Revenue in Respiratory Tract Infection Treatment Business (2016-2021)
11.12.5 Teva Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Respiratory Tract Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of NSAIDS
Table 4. Key Players of Cough Suppressant
Table 5. Key Players of Nose Decongestant
Table 6. Key Players of Others
Table 7. Global Respiratory Tract Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Respiratory Tract Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Respiratory Tract Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Respiratory Tract Infection Treatment Market Share by Regions (2016-2021)
Table 11. Global Respiratory Tract Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Respiratory Tract Infection Treatment Market Share by Regions (2022-2027)
Table 13. Respiratory Tract Infection Treatment Market Trends
Table 14. Respiratory Tract Infection Treatment Market Drivers
Table 15. Respiratory Tract Infection Treatment Market Challenges
Table 16. Respiratory Tract Infection Treatment Market Restraints
Table 17. Global Respiratory Tract Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Respiratory Tract Infection Treatment Market Share by Players (2016-2021)
Table 19. Global Top Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Tract Infection Treatment as of 2020)
Table 20. Ranking of Global Top Respiratory Tract Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Respiratory Tract Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Respiratory Tract Infection Treatment Product Solution and Service
Table 24. Date of Enter into Respiratory Tract Infection Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Respiratory Tract Infection Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Respiratory Tract Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Respiratory Tract Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Respiratory Tract Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Respiratory Tract Infection Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Respiratory Tract Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Respiratory Tract Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Respiratory Tract Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Respiratory Tract Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Respiratory Tract Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Respiratory Tract Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Respiratory Tract Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Respiratory Tract Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Respiratory Tract Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Respiratory Tract Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Respiratory Tract Infection Treatment Product
Table 67. Abbott Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Respiratory Tract Infection Treatment Product
Table 72. AstraZeneca Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Recent Development
Table 74. Abbvie Company Details
Table 75. Abbvie Business Overview
Table 76. Abbvie Respiratory Tract Infection Treatment Product
Table 77. Abbvie Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 78. Abbvie Recent Development
Table 79. Boehringer Ingelheim Company Details
Table 80. Boehringer Ingelheim Business Overview
Table 81. Boehringer Ingelheim Respiratory Tract Infection Treatment Product
Table 82. Boehringer Ingelheim Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 83. Boehringer Ingelheim Recent Development
Table 84. Cipla Pharmaceutical Company Details
Table 85. Cipla Pharmaceutical Business Overview
Table 86. Cipla Pharmaceutical Respiratory Tract Infection Treatment Product
Table 87. Cipla Pharmaceutical Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 88. Cipla Pharmaceutical Recent Development
Table 89. GlaxoSmithkline Company Details
Table 90. GlaxoSmithkline Business Overview
Table 91. GlaxoSmithkline Respiratory Tract Infection Treatment Product
Table 92. GlaxoSmithkline Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 93. GlaxoSmithkline Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Respiratory Tract Infection Treatment Product
Table 97. Pfizer Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Respiratory Tract Infection Treatment Product
Table 106. Novartis Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 107. Novartis Recent Development
Table 108. Roche Company Details
Table 109. Roche Business Overview
Table 110. Roche Respiratory Tract Infection Treatment Product
Table 111. Roche Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 112. Roche Recent Development
Table 113. Sanofi Company Details
Table 114. Sanofi Business Overview
Table 115. Sanofi Respiratory Tract Infection Treatment Product
Table 116. Sanofi Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 117. Sanofi Recent Development
Table 118. Teva Company Details
Table 119. Teva Business Overview
Table 120. Teva Respiratory Tract Infection Treatment Product
Table 121. Teva Revenue in Respiratory Tract Infection Treatment Business (2016-2021) & (US$ Million)
Table 122. Teva Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Tract Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. NSAIDS Features
Figure 4. Cough Suppressant Features
Figure 5. Nose Decongestant Features
Figure 6. Others Features
Figure 7. Global Respiratory Tract Infection Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Respiratory Tract Infection Treatment Report Years Considered
Figure 11. Global Respiratory Tract Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Respiratory Tract Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Respiratory Tract Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Respiratory Tract Infection Treatment Market Share by Regions (2022-2027)
Figure 15. Global Respiratory Tract Infection Treatment Market Share by Players in 2020
Figure 16. Global Top Respiratory Tract Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Tract Infection Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Respiratory Tract Infection Treatment Revenue in 2020
Figure 18. Global Respiratory Tract Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Respiratory Tract Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 22. North America Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 23. North America Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 24. United States Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 28. Europe Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 29. Europe Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 30. Germany Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Respiratory Tract Infection Treatment Market Share by Region (2016-2027)
Figure 40. China Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Respiratory Tract Infection Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Respiratory Tract Infection Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Respiratory Tract Infection Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Respiratory Tract Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 61. Abbvie Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 63. Cipla Pharmaceutical Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 64. GlaxoSmithkline Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 70. Teva Revenue Growth Rate in Respiratory Tract Infection Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5010 2021年4月 93Pages
QYResearch社発行の本調査資料では、気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、...

世界の下気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Lower Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3477 2021年4月 98Pages
QYResearch社発行の本調査資料では、下気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（支持療法、ホスピタルケア、医薬品、ワクチン）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、...

世界の尿路感染症治療市場規模・現状・予測（2021年-2027年）

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5835 2021年4月 98Pages
QYResearch社発行の本調査資料では、尿路感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（複雑UTI、再発性複雑UTI、単純UTI、神経因性膀胱感染症、その他）、用途別市場規模（病院薬局、婦人科及び泌尿器科クリニック、ドラッグス...

世界の尿路感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Urinary Tract Infection Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5834 2021年4月 91Pages
QYResearch社発行の本調査資料では、尿路感染症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（キノロン、ペニシリン＆組み合わせ、セファロスポリン、テトラサイクリン、スルホンアミド、ニトロフラン、その他）、用途別市場規模（病院薬局、...

世界の院内感染性尿路感染症検査市場規模・現状・予測（2021年-2027年）

Global Hospital-acquired Urinary Tract Infection Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2922 2021年4月 97Pages
QYResearch社発行の本調査資料では、院内感染性尿路感染症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アッセイキット・消耗品、機器）、用途別市場規模（病院・外来、診断臨床検査室）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の院内感染性尿路感染症市場規模・現状・予測（2021年-2027年）

Global Hospital Acquired Urinary Tract Infection Market Size, Status and Forecast 2021-2027
QYR2104Z2907 2021年4月 92Pages
QYResearch社発行の本調査資料では、院内感染性尿路感染症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（微生物検査機器、試薬・消耗品、感染予防・監視ソフトウェア）、用途別市場規模（疾病検査、薬剤耐性検査）、主要地域別市場規模（北米、アメ...

世界の院内感染性尿路感染症市場規模・現状・予測（2021年-2027年）

世界の呼吸器ウイルス感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Respiratory Virus Infection Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z5011 2021年4月 92Pages
QYResearch社発行の本調査資料では、呼吸器ウイルス感染症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、診療所...

世界の耳感染症治療市場規模・現状・予測（2021年-2027年）

Global Ear Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2028 2021年4月 90Pages
QYResearch社発行の本調査資料では、耳感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、治療薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イ...

世界の院内感染症治療市場規模・現状・予測（2021年-2027年）

Global Hospital Acquired Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2904 2021年4月 130Pages
QYResearch社発行の本調査資料では、院内感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（尿路感染症、換気装置関連肺炎、手術部位感染症、血流感染症、胃腸感染症、ENT感染症、皮膚感染症、骨感染症）、用途別市場規模（病院薬局、小売...

世界の気道感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Tract Infection Treatment Market The global Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
世界の下気道感染症治療市場規模・現状・予測（2021年-2027年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…
世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
世界の院内感染性尿路感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital-acquired Urinary Tract Infection Testing Market The global Hospital-acquired Urinary Tract Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard …
世界の院内感染性尿路感染症市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital Acquired Urinary Tract Infection Market The global Hospital Acquired Urinary Tract Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in anal…